NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported a 1 percent year-over-year decline in revenues for the third quarter but still beat the average Wall Street estimate on the top and bottom lines. 

For the three months ended Sept. 26, the company reported total revenues of $4.12 billion, down from $4.17 billion in the year-ago quarter but still above the analysts' average estimate of $4.10 billion. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.